Collaborations & Alliances
Related Searches:
Filter by:
511 - 525 of 1095 results
December 16, 2010
GlaxoSmithKline and Impax Pharmaceuticals entered an agreement for the development and commercialization of IPX066, Impax’s extended release carbidopa-levodopa product, outside the U.S. and Taiwan.
Read More »
December 16, 2010
Galapagos has achieved a $4.7 million milestone in its strategic alliance with Roche.
Read More »
December 13, 2010
Tanabe Research Laboratories, Inc. (TRL) has entered into a partnership with Anaphore, Inc. for the research and preclinical development of novel protein therapies for autoimmune diseases based on Anaphore's Atrimer technology.
Read More »
December 10, 2010
MorphoSys AG has signed a non-exclusive license and technology transfer agreement between its subsidiary Sloning BioTechnology GmbH and Pfizer.
Read More »
December 2, 2010
Advinus Therapeutics and Corning Inc. entered a collaboration to bring Corning Epic label-free detection technology to India.
Read More »
November 30, 2010
Array BioPharma has achieved a $10 million clinical research milestone in its collaboration with Celgene, with the planned initiation of a Phase I dose escalation trial in cancer patients with ARRY-382, a small molecule cFMS inhibitor.
Read More »
November 29, 2010
Quintiles and London Genetics have entered a strategic alliance to offer pharmacogenetics solutions to the biopharmaceutical industry in an effort to advance personalized medicine.
Read More »
November 23, 2010
Evotec AG, through the NEU(2) consortium, has signed an agreement with Merck KGaA to develop pre-clinical candidates for an undisclosed neurological disease.
Read More »
November 22, 2010
Boehringer Ingelheim and F-star, an antibody engineering company based in Vienna, Austria, have entered a collaboration and license agreement for the discovery of new antibody-derived therapeutic products using F-star’s Modular Antibody Technology.
Read More »
November 17, 2010
U.S., EU deal to speed hybrid detailing model
Read More »
November 17, 2010
DOS platforms to support Eisai portfolio
Read More »
November 11, 2010
Watson Pharmaceuticals’ Eden Biodesign, Ltd., has entered a non-exclusive vendor network agreement with Crucell, under which Eden Biodesign becomes an authorized provider of process development and cGMP manufacturing services using Crucell’s P
Read More »
November 2, 2010
Quintiles and Dako, a provider of tissue-based cancer diagnostics, have entered a strategic alliance to advance personalized medicine through the development of targeted therapies and companion diagnostics.
Read More »
November 1, 2010
Valeant Pharmaceuticals and Kadmon Pharmaceuticals have entered two strategic agreements for the development and commercialization of taribavirin and the marketing of ribavirin in the treatment of viral diseases.
Read More »
October 26, 2010
Companies fill in gaps in CMC, form dev, analytical services
Read More »
511 - 525 of 1095 results
